Skip to content

The Beachbody Company BODI Short-term restricted investments

Short-term restricted investments at other companies

UroGen Pharma logo
UroGen PharmaURGN
$177K+0.6%
Intercontinental Exchange logo
Intercontinental ExchangeICE
$884M+43.3%
VAL
Value LineVALU
$305K0.0%
UFP Industries, Inc. logo
UFP Industries, Inc.UFPI
$51.3M+22.0%
Ingevity logo
IngevityNGVT
$24.7M
DocGo logo
DocGoDCGO
$13.12M

Other financials

Income statement

See full
Revenue$54.3M-25.0%
Gross profit$39.0M-24.3%
Operating income$3.1M+185%
Net income$2.3M+140%
EPS (diluted)$0.30+136%

Balance sheet

See full
Cash & equivalents$36.6M+102%
Total debt$23.6M+43.4%
Total equity$34.4M+42.9%
Total assets$143.1M-6.2%

Cash flow

See full
Operating cash flow-$1.0M-144%
CapEx$684.0K-1.4%
Free cash flow-$1.7M-205%

Valuation

See full
Market cap$74.01M+194%
Enterprise value$60.97M+167%
P/S0.3×+0.2×

Profitability

See full
Gross margin73.3%+3.9pp
Operating margin5.3%+3.0pp
Net margin-15.1%-3.8pp
FCF margin6%+4.8pp

Returns & leverage

See full
Return on equity-102.7%+0.3pp
Debt / equity0.7×0.0×
Current ratio0.8×+0.2×

Where this comes from

Reported directly by The Beachbody Company in its filing.

Tagged under the XBRL concept us-gaap:RestrictedInvestmentsCurrent.

The official record: The Beachbody Company’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Beachbody Company's short-term restricted investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Beachbody Company's short-term restricted investments?
The Beachbody Company (BODI) reported short-term restricted investments of $4.25M in Q1 2026.
How has The Beachbody Company's short-term restricted investments changed year-over-year?
The Beachbody Company's short-term restricted investments decreased by 0.0% year-over-year, from $4.25M to $4.25M.
What is the long-term trend for The Beachbody Company's short-term restricted investments?
Over 2 years (2023 to 2025), The Beachbody Company's short-term restricted investments has grown at a 0.0% compound annual growth rate (CAGR), from $4.25M to $4.25M.